StockData
MDLNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Medline Inc.

Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Aug 5, 2026
$35.19−0.77 (-2.14%)

Close on Oct 19, 2026

Market cap
$30.29B
P/E (TTM)
–
Dividend yield
–

SEC filings

13 of Medline's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Current report8-KOct 21, 2026Oct 21, 2026SEC EDGAR
Current report8-KOct 13, 2026Oct 15, 2026SEC EDGAR
Quarterly report10-QJun 27, 2026Aug 5, 2026SEC EDGAR
Current report8-KAug 5, 2026Aug 5, 2026SEC EDGAR
Current report8-KJul 7, 2026Jul 9, 2026SEC EDGAR
Current report8-KJun 11, 2026Jun 12, 2026SEC EDGAR
Current report8-KMay 28, 2026Jun 2, 2026SEC EDGAR
Quarterly report10-QMar 28, 2026May 6, 2026SEC EDGAR
Current report8-KMay 6, 2026May 6, 2026SEC EDGAR
Proxy statementDEF 14AJun 11, 2026Apr 23, 2026SEC EDGAR
Annual report10-KDec 31, 2025Feb 25, 2026SEC EDGAR
Current report8-KFeb 25, 2026Feb 25, 2026SEC EDGAR
Current report8-KDec 16, 2025Dec 22, 2025SEC EDGAR